NEW STUDY. A study by researchers in the Department of Rheumatology and Inflammation identifies a mechanism in the signal system that activates B cells. The findings could enable new ways of treating cancer diseases caused by B cells becoming malignant, such as certain forms of lymphoma. This research is fundamental and increases the understanding of the cascade of signals that lead to activation of a B cell when it encounters…
Carolina Guibentif named one of research leaders of the future
YOUNG RESEARCHERS. Carolina Guibentif, a researcher in the Department of Microbiology and Immunology, uses single-cell analysis to identify genes and mechanisms that have an important bearing on prenatal cancers. Her dream is to develop research that could help the early identification of newborns at risk of developing cancer. Naturally, Guibentif is delighted to be among those recently named a Research Leader of the Future by the Swedish Foundation for Strategic…
Possible new cancer treatment target discovered
NEW STUDY. Researchers at the University of Gothenburg have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice. This discovery may potentially enable future development of new drugs against a range of cancer diseases. In a research article published in the journal Nature Communications, the Gothenburg scientists have described their discovery. It concerns a protein that binds genetic material and, as the researchers now show, also…
Cancer care at Sahlgrenska University Hospital receives crucial seal of approval
RESEARCH CONDITIONS. The Sahlgrenska Cancer Center (SCC) takes a seat among the top cancer hospitals in Europe. This week it received approval for its application to become a Comprehensive Cancer Center. The accreditation has been in the works since 2019, in collaboration with Regional Cancer Center West and Sahlgrenska Academy. “This confirms our position on the absolute cutting edge of research and care worldwide,” says Hospital Director and Professor Ann-Marie…
The Swedish Cancer Society funding clinical research position for Erik Elias
GRANT. Erik Elias, researcher at the University of Gothenburg and surgeon at Sahlgrenska University Hospital has received the Swedish Cancer Society’s Junior Clinical Investigator Award. The award enables him to devote at least half of his work time to researching neuroendocrine tumors over six years. Twenty-nine researchers around Sweden are sharing SEK 117.2 million thanks to fundraising efforts by the Swedish Cancer Society. One of these researchers is Erik Elias,…